Sun Pharma Advanced Research Company Ltd — Quarterly Results & Earnings

₹114.89

-8.03%

Profit Growth YoY29.45%Latest quarter

Sales Growth YoY-38.88%Latest quarter

Sales CAGR 5Y-1.35%5 year compound

Profit CAGR 5Y-1.73%5 year compound

📋

Quarterly Performance

YoY Profit Growth+29.45%

🔥 Exceptional growth

YoY Sales Growth-38.88%

🔴 Significant decline

OPM 5Y Average

Operating profit margin

-163.17%

EPS Growth 5Y

2.39%

Interest Coverage

Higher = safer debt servicing

-11.81

ROE

N/A

ROCE

-297.83%

💡

Growth Analysis

Sun Pharma Advanced Research Company Ltd reported YoY profit growth of 29.45% and revenue growth of -38.88% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at -1.35% and profits at -1.73% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Sun Pharma Advanced Research Company Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.